Macrophages | CHOP Research Institute
 

Macrophages

Dr. Bailis aims to understand how metabolism underlies immunology and disease, by controlling the biochemistry of cells and tissues. His lab does so using in vitro and in vivo CRISPR engineering of primary human and mouse immune cells, with the goal of developing diet and metabolite based therapies.

E-mail:
bailisw [at] chop.edu

The Rivella Laboratory uses lentiviral vectors for modulation of gene expression and gene transfer for the cure of hemoglobinopathies.

Scientists in the Hill Lab seek to understand how the immune system contributes to the two most common chronic diseases of childhood: allergy and obesity. The lab uses clinical and epidemiological information to guide basic and translational research aimed at understanding the genetic, epigenetic, and immunologic basis of these diseases.

Steven D. Douglas, MD, and his laboratory team investigate the immunopathogenesis of HIV/AIDS in relation to monocytes/macrophages, immune activation, immune suppression, and inflammation. The laboratory also has projects which examine the role of the neurokinin-1 receptor in inflammation and depression.

All biological processes operate under biochemical constraints. The Bailis Lab aims to understand how metabolism controls the development and functional differentiation of the hematopoietic system by setting the biochemical potential of cells and tissues, using in vitro and in vivo CRISPR screening in primary immune cells.

Dr. Douglas has extensive laboratory experience investigating the cellular immunology of HIV/AIDS, primary immune deficiency diseases, and cellular immunopathologies. In addition, he has had significant involvement in studies related to immunological interactions.

E-mail:
douglasa [at] chop.edu
Published on
Oct 16, 2018
The Silver Award and Lecture honors Steven Douglas, MD, for his significant contributions and mentorship in the field of pediatric HIV and AIDS.